Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q3 2025 (September 30)2holders
0new positions
0sold out
$0.38avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Clear Street Group Inc. ($24K) and UBS Group AG ($397).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 190 shares sold, net −190 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Clear Street Group Inc. | — | — | 63,685 | $24K |
| UBS Group AG | — | Reduce -12.9% | 1,280 | $397 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.